주식/증권 📈 긍정적 Regeneron expects 2027 R&D expense to rise by a mid-teens percentage while recording a $1B Sanofi upfront payment in Q4 Seeking Alpha - Market News 10/30/2026 06:40:17 PM 3회 원문 기사 보기